Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY ISSUE OF APRIL 09, 2004 FBO #0865
MODIFICATION

65 -- Pharmaceuticals

Notice Date
4/7/2004
 
Notice Type
Modification
 
NAICS
424210 — Drugs and Druggists' Sundries Merchant Wholesalers
 
Contracting Office
Department of Health and Human Services, National Institutes of Health, National Institute of Allergy & Infectious Diseases/AMOB, 10401 Fernwood Drive, Suite 2NE70, MSC 4811, Bethesda, MD, 20817
 
ZIP Code
20817
 
Solicitation Number
NIAID-OCR-04-64
 
Point of Contact
Terrie Nestor, Contract Specialist, Phone 301-402-6790, Fax 301-480-0689,
 
E-Mail Address
tnestor@niaid.nih.gov
 
Description
****Due to formatting inconsistencies, the registered trademark symbols were converted to question marks. Please note that the question marks after the brand names of the requested pharmaceuticals indicate that they are registered trademarks.**** The National Institute of Allergy and Infectious Diseases (NIAID), Acquisitions Management and Operations Branch (AMOB) has an unrestricted requirement for pharmaceutical distribution within South Africa. NIAID intends to award a one year contract with the option for four additional years beginning on or before August 1, 2004. The resulting contract will also contain the provision at FAR 52.217-8. The contractor will be responsible for providing the antiretroviral drugs (ARV) identified below to the South African National Defense Force (SANDF) pharmacy depot upon receipt of individual delivery orders. All ARVs are brand name specific, identified by a manufacturer's commercial item description, and conform to the manufacturer's commercial specifications. Offerors must demonstrate that they have an established and ongoing contractual relationship and are in good standing with the manufacturers of the antiretroviral drugs; they have adequate storage space and optimal storage conditions to maintain the antiretroviral drugs from the time of receipt from the manufacturer to delivery to SANDF depot; they have the infrastructure to fulfill the order placement, delivery, and invoice requirements as outlined in the Statement of Work and can do so in a timely manner; and they are able to comply with the distribution requirements of the Medicines Control Council (MCC) of South Africa. The required ARVs are as follows: Didanosine (Videx?, Videx EC?, Bristol-Myers Squibb) - various dosages and formulations; Efavirenz (Stocrin?, MSD) - 200mg capsules, 50mg capsules; Lamivudine (Epivir? or 3TC?, Glaxo Smith Kline) - 150mg tablet or oral solution; Lopinavir/ritonavir (Kaletra?, Abbott) - 133mg/33mg capsules, oral liquid formulation; Nevirapine (Viramune?, Boehringer-Ingelheim) - 200mg capsules, 50mg/5mL suspension; Stavudine (Zerit?, Bristol-Myers Squibb) - 40mg, 30mg, 20mg capsules and 1mg/mL oral solution; Zidovudine (Retrovir?, Glaxo Smith Kline) - 300mg tablets, 100mg capsules, and oral syrup. Substitutions or changes to the identified ARVs may be required over the life of the contract. The solicitation may result in multiple awards. The NIAID intends to award a commercial item, FFP/EPA contract(s). The solicitation will be available for download on or around April 14, 2004 at www.fedbizopps.gov. Hard copies of the solicitation will not be distributed. Please refer any questions in writing to Terrie Nestor at tnestor@niaid.nih.gov.
 
Place of Performance
Address: South Africa
 
Record
SN00561532-W 20040409/040407211840 (fbodaily.com)
 
Source
FedBizOpps.gov Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.